CN Stock MarketDetailed Quotes

000627 Hubei Biocause Pharmaceutical

Watchlist
  • 1.73
  • +0.01+0.58%
Market Closed Jul 12 15:00 CST
8.55BMarket Cap-10880P/E (TTM)

Hubei Biocause Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hubei Biocause Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 30, 2024

Revenue(YoY)

17.49B

-20.25%
EPS(YoY)

-0.02

-282.00%
Analyst Rating

No Data

Hubei Biocause Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

No Data

Hubei Biocause Pharmaceutical Earnings Reports

  • Hubei Biocause Pharmaceutical: 2024-043- Hubei Biocause Pharmaceutical's half-year performance forecast for 2024.

    Jul 8 12:00 ET

  • Hubei Biocause Pharmaceutical: 2024 First Quarter Report

    Apr 29 12:00 ET

  • Hubei Biocause Pharmaceutical: 2023 ANNUAL REPORT

    Apr 29 12:00 ET

  • Hubei Biocause Pharmaceutical: 2023 Annual Report Summary

    Apr 29 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg